The aim of this preclinical study was to examine the cell killing effect of the HDAC inhibitors CUDC-101 and SAHA in combination with radiation in pancreatic adenocarcinoma (PDAC) cancer cell lines. This evidence concerns the gene HDAC9 and cancer.